Skip to main content
S&P 5007,663.43-1.21%DOW52,867.98+0.02%NASDAQ26,008.86-2.60%BTC$81,395.00-3.35%ETH$2,391.93-3.37%GOLD$4,036.20-0.60%OIL$99.27-0.20%
Smart Investors Daily
SID Premium
MR

OTC · MRMD

MariMed Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$0.06

Up+$0.00 (+0.18%)

Updated Oct 23, 2026, 6:09 AM

SID Score

4.4/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
29.63M
P/E ratio
-1.84
Dividend yield
0.00%
52-week range
— – —
Volume
110.74K
Avg. volume
1.2M

Price performance · MRMD

MRMD price history

1M range · 0 trading sessions · Daily adjusted prices

MRMD does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest MRMD news

The latest Smart Investors Daily articles mentioning MRMD.

Stock researchCompany · Overview

MRMD research

Overview

Company profile and research snapshot.

Company profile

MARIMED INC

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$2.25
Implied upside
—
Analysts
—
MRMD recent ratings
DateFirmRatingTarget
Nov 6, 2023Zuanic & AssociatesOverweight—
Oct 28, 2022BTIGBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 24, 2026

MariMed’s Betty’s Eddies Spreads Importance of Cancer Screening Education and Awareness this October through Partnership with Keep A Breast Foundation

Fourth Annual Collaboration Coincides with Breast Cancer Awareness MonthNORWOOD, Mass., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Betty’s Eddies™, the all-natural cannabis fruit chews handcrafted for specific health and wellness effects, announced today its fourth annual collaboration with the Keep A Breast Foundation (“KAB”). The collaboration, which furthers the brand’s commitment to breast cancer awareness, early screening education, and community support, kicks off this week as a lead-up to October

Yahoo · Sep 23, 2026

MariMed Files Definitive Proxy Statement for Special Meeting of Stockholders to Approve Proposed Reverse Stock Split

NORWOOD, Mass., Sept. 23, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced that it has filed a definitive proxy statement with the U.S. Securities and Exchange Commission (“SEC”) in connection with a Special Meeting of Stockholders (the “Special Meeting”) to seek stockholder approval of a proposed reverse stock split of the Company’s common stock (the “Revers

Yahoo · Sep 17, 2026

MariMed Announces Thrive Wellness Dispensary Opening in Columbus, Ohio

NORWOOD, Mass., Sept. 17, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced the September 18th opening of Thrive Dispensary Columbus, the Company’s 14th Thrive Dispensary location in five states and its second in Ohio. MariMed also operates Thrive Dispensary Tiffin in the western part of the state. Thrive Dispensary Columbus, located on the city’s east side at

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By